Literature DB >> 14967397

Duration of gonadotropin-releasing hormone antagonist administration does not affect the outcome of subsequent frozen-thawed cycles.

Kostantinos Zikopoulos, Efstratios M Kolibianakis, Michael Camus, Herman Tournaye, Etienne Van den Abbeel, Hubert Joris, André Van Steirteghem, Paul Devroey.   

Abstract

The duration of administration of GnRH antagonist in cycles stimulated with recombinant FSH for IVF/intracytoplasmic sperm injection does not affect the probability of blastocyst replacement and of achieving an ongoing pregnancy in subsequent frozen-thawed cycles.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14967397     DOI: 10.1016/j.fertnstert.2003.08.009

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  3 in total

1.  Outcome of frozen-thawed blastocysts derived from gonadotropin releasing hormone agonist or antagonist cycles.

Authors:  Robert Medved; Irma Virant-Klun; Helena Meden-Vrtovec; Tomaz Tomazevic
Journal:  J Assist Reprod Genet       Date:  2006-07-06       Impact factor: 3.412

2.  Effects of gonadotrophin releasing hormone analogues on human endometrial stromal cells and embryo invasion in vitro.

Authors:  Petra A B Klemmt; Fang Liu; Janet G Carver; Celine Jones; Dorothea Brosi; Jonathan Adamson; Helen J Mardon; Enda McVeigh
Journal:  Hum Reprod       Date:  2009-06-11       Impact factor: 6.918

3.  Effect of Pre-ovulatory Single Dose GnRH agonist Therapy on IVF Outcome in GnRH Antagonist Cycles; A Prospective Study.

Authors:  Harpreet Kaur; Deepika Krishna; Nivedita Shetty; Sandhya Krishnan; M S Srinivas; Kamini A Rao
Journal:  J Reprod Infertil       Date:  2012-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.